Zegerid

DRUG4 trials

Sponsors

Bayer, Norgine

Conditions

Acid RefluxGastro Oesophageal Reflux DiseaseGastroesophageal RefluxHuman ExperimentationIntragastric Acidity

Phase 1

A Three-Period Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20mg Capsule, Zegerid 20mg Powder for Oral Suspension and Losec 20mg Capsule in Healthy Adult Volunteers Under Fasting Conditions

CompletedNCT01710995

NorgineAcid Reflux, Gastro Oesophageal Reflux Disease

Start: 2010-10-31End: 2011-02-28Updated: 2012-10-19

Phase 3

Study to Compare Gastric Inhibition of Two Proton Pump Inhibitors (CL2008-18)(P07815)(COMPLETED)

CompletedNCT01005719

BayerHuman Experimentation

Start: 2009-09-30End: 2010-01-31Updated: 2015-03-11

Pharmacodynamic Study Comparing the Effects of Two Different Forms of Omeprazole (P07812) (COMPLETED)

CompletedNCT01077076

BayerIntragastric Acidity

Start: 2008-12-31End: 2009-03-31Updated: 2015-03-11

Phase III Study Comparing Zegerid® With Losec® for the Relief of Heartburn Associated With Gastroesophageal Reflux Disease

CompletedNCT01493089

NorgineGastroesophageal Reflux

Start: 2011-04-30End: 2011-10-31Updated: 2013-08-13

Related Papers

Challenges of Correlating pH Change with Relief of Clinical Symptoms in Gastro Esophageal Reflux Disease: A Phase III, Randomized Study of Zegerid versus Losec

PLoS ONE2015-02-2313 citations